Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis.

Complication Infection Outcome Perioperative mortality Radical cystectomy Smoking exposure Urothelial bladder cancer

Journal

European urology oncology
ISSN: 2588-9311
Titre abrégé: Eur Urol Oncol
Pays: Netherlands
ID NLM: 101724904

Informations de publication

Date de publication:
08 2021
Historique:
received: 18 06 2020
revised: 23 09 2020
accepted: 13 10 2020
pubmed: 9 11 2020
medline: 2 2 2022
entrez: 8 11 2020
Statut: ppublish

Résumé

Smoking habit at the time of surgery is associated with higher perioperative complications and mortality across different types of surgeries. In recent years, several studies have attempted to explore the influence of smoking on perioperative outcomes following radical cystectomy (RC) for urothelial bladder cancer (UBC) with contradictory results. To systematically investigate and meta-analyze the association between smoking habit and perioperative morbidity and mortality in UBC patients treated with RC. A systematic review of the literature published between January 2000 and January 2020 investigating the impact of smoking habit on perioperative outcomes of patients treated with RC for UBC was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement and the Cochrane Handbook for Systematic Reviews of Interventions. Overall, 27 articles involving 27 854 patients were included in the systematic review, and of these, 11 studies were included in the meta-analysis. The studies included showed a moderate to high risk of bias. Smoking status (smokers vs nonsmokers) was significantly associated with the onset of major postoperative complications (hazard ratio [HR] 1.87, 95% confidence interval [CI] 1.51-2.32; I Smoking status at the time of RC is associated with increased risk for major postoperative complications, infections, and mortality. These results suggest the need for strict postoperative monitoring in smokers due to the increased risk of experiencing adverse events and underline the need for intensive smoking cessation interventions in the preoperative setting. In this study, we reviewed the impact of smoking habit on perioperative outcomes following radical cystectomy (RC). Based on the available data, the impact of smoking on morbidity and mortality after RC is significant and relevant; as such, every effort should be made in the preoperative setting to encourage smoking cessation.

Identifiants

pubmed: 33160975
pii: S2588-9311(20)30171-1
doi: 10.1016/j.euo.2020.10.006
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

580-593

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Riccardo Tellini (R)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Andrea Mari (A)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Gianluca Muto (G)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Giovanni Enrico Cacciamani (GE)

USC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Matteo Ferro (M)

Division of Urology, European Institute of Oncology-IRCCS, Milan, Italy.

Judith Stangl-Kremser (J)

Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Riccardo Campi (R)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Francesco Soria (F)

Division of Urology, Department of Surgical Sciences, University of Studies of Torino, Turin, Italy.

Michael Rink (M)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Evanguelos Xylinas (E)

Department of Urology, Bichat-Claude Bernard Hospital, APHP, Paris University, Paris, France.

Andrea Minervini (A)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Alberto Briganti (A)

Department of Urology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy.

Francesco Montorsi (F)

Department of Urology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy.

Morgan Roupret (M)

Urology, GRC 5 PREDICTIVE ONCO-URO, AP-HP, Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France.

Shahrokh F Shariat (SF)

Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; Department of Urology, University of Jordan, Amman, Jordan; European Association of Urology research foundation, Arnhem, The Netherlands.

Marco Moschini (M)

Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: marco.moschini87@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH